(Total Views: 859)
Posted On: 11/01/2020 9:17:55 PM
Post# of 155038
Dave....
"The quickest route to profitability is Covid. With profits, all trials for all indications can be funded. In the short run, efficacy in Covid will create the economic capability for CYDY to reach its potential. Without it, you're back to 75 cents a share and scrounging for investors to survive."
Scrounging to survive? I think anyone who invests assets needed to "survive" is being foolish. You might be over dramatizing?
".... Truthfully, at this point nothing else matters because with enough funds, you can catch up very quickly. Without the funding, CYDY is a beggar and we're looking at years of scrounging to get anything done. That's the reality."
Wrong, IMO. We would be awaiting HIV BLA, cancer, etc. for 2021. Settle down... We keep rehashing the same impatient push - pull.
"The quickest route to profitability is Covid. With profits, all trials for all indications can be funded. In the short run, efficacy in Covid will create the economic capability for CYDY to reach its potential. Without it, you're back to 75 cents a share and scrounging for investors to survive."
Scrounging to survive? I think anyone who invests assets needed to "survive" is being foolish. You might be over dramatizing?
".... Truthfully, at this point nothing else matters because with enough funds, you can catch up very quickly. Without the funding, CYDY is a beggar and we're looking at years of scrounging to get anything done. That's the reality."
Wrong, IMO. We would be awaiting HIV BLA, cancer, etc. for 2021. Settle down... We keep rehashing the same impatient push - pull.
(8)
(0)
